Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Global Cord Blood Corpora...

    NYSE: CO · Real-Time Price · USD
    2.99
    0.77 (34.68%)
    At close: Jun 09, 2023, 3:43 PM

    Global Cord Blood Statistics

    Share Statistics

    Global Cord Blood has 133.91M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 133.91M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 35.63M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is 5.92 and the forward PE ratio is null. Global Cord Blood's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 5.92

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 2.39

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.61

    P/FCF Ratio

    n/a
    		 5

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Global Cord Blood has an Enterprise Value (EV) of -3.69B.

    EV / Sales

    n/a
    		 -2.97

    EV / EBITDA

    n/a
    		 -5.62

    EV / EBIT

    n/a
    		 -6.02

    EV / FCF

    n/a
    		 -6.22

    Financial Position

    The company has a current ratio of 10.73, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 10.73

    Quick Ratio

    n/a
    		 10.66

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 10.27% and Return on Invested Capital is 10.13%.

    Return on Equity

    n/a
    		 10.27%

    Return on Assets

    n/a
    		 5.87%

    Return on Invested Capital

    n/a
    		 10.13%

    Revenue Per Employee

    n/a
    		 $1,034,321.96

    Profits Per Employee

    n/a
    		 $416,859.4

    Employee Count

    n/a
    		 1,202

    Asset Turnover

    n/a
    		 0.15

    Inventory Turnover

    n/a
    		 4

    Taxes

    Income Tax

    n/a
    		 118.35M

    Effective Tax Rate

    n/a
    		 18.85%

    Stock Price Statistics

    The stock price has increased by 0.08% in the last 52 weeks. The beta is -0.04, so Global Cord Blood's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.04

    52-Week Price Change

    n/a
    		 0.08%

    50-Day Moving Average

    n/a
    		 2.95

    200-Day Moving Average

    n/a
    		 2.91

    Relative Strength Index (RSI)

    n/a
    		 51.83

    Average Volume (20 Days)

    n/a
    		 177,415

    Income Statement

    In the last 12 months, Global Cord Blood had revenue of 1.24B and earned 501.06M in profits. Earnings per share was 4.12.

    Revenue

    n/a
    		 1.24B

    Gross Profit

    n/a
    		 1.06B

    Operating Income

    n/a
    		 608.87M

    Net Income

    n/a
    		 501.06M

    EBITDA

    n/a
    		 628.78M

    EBIT

    n/a
    		 589.27M

    Earnings Per Share (EPS)

    n/a
    		 4.12
    Full Income Statement

    Balance Sheet

    The company has 6.66B in cash and 147K in debt, giving a net cash position of 6.66B.

    Cash & Cash Equivalents

    n/a
    		 6.66B

    Total Debt

    n/a
    		 147K

    Net Cash

    n/a
    		 6.66B

    Retained Earnings

    n/a
    		 2.89B

    Total Assets

    n/a
    		 1.35B

    Working Capital

    n/a
    		 991.98M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 613.61M and capital expenditures -19.79M, giving a free cash flow of 593.82M.

    Operating Cash Flow

    n/a
    		 613.61M

    Capital Expenditures

    n/a
    		 -19.79M

    Free Cash Flow

    n/a
    		 593.82M

    FCF Per Share

    n/a
    		 4.89
    Full Cash Flow Statement

    Margins

    Gross margin is 85.26%, with operating and profit margins of 48.97% and 40.3%.

    Gross Margin

    n/a
    		 85.26%

    Operating Margin

    n/a
    		 48.97%

    Pretax Margin

    n/a
    		 50.5%

    Profit Margin

    n/a
    		 40.3%

    EBITDA Margin

    n/a
    		 52.83%

    EBIT Margin

    n/a
    		 48.97%

    FCF Margin

    n/a
    		 47.76%

    Dividends & Yields

    CO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 16.88%

    FCF Yield

    n/a
    		 20.01%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for CO.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $64.56

    Lynch Upside

    n/a
    		 2059.2%

    Graham Number

    n/a
    		 61.02

    Graham Upside

    n/a
    		 1940.8%

    Scores

    Altman Z-Score

    n/a
    		 4.14

    Piotroski F-Score

    n/a
    		 8

    Add to Watchlist